Results 221 to 230 of about 28,984 (253)

Carbon-ion radiotherapy for clear cell odontogenic carcinomas. [PDF]

World J Surg Oncol
Ikawa H, Koto M, Fugo K, Takiyama H, Isozaki T, Shinoto M, Yamada S, Ishikawa H.   +7 more
europepmc   +1 more source

Comparison of carbon ion radiotherapy and transarterial chemoembolization for unresectable solitary hepatocellular carcinoma >3 cm: a propensity score-matched analysis. [PDF]

J Radiat Res
Fukushima T, Kobayashi S, Katoh H, Hamaguchi T, Tozuka Y, Asai Y, Tezuka S, Ueno M, Morimoto M, Furuse J, Maeda S.   +10 more
europepmc   +1 more source

Secondary Osteosarcoma After Carbon-Ion Radiotherapy for Desmoid-Type Fibromatosis: A Case Report. [PDF]

Cancer Rep (Hoboken)
Aketo M, Emori M, Takada K, Murase K, Arihara Y, Shimizu J, Murahashi Y, Okamoto M, Sugita S, Teramoto A.   +9 more
europepmc   +1 more source

Current Status of Carbon Ion Radiotherapy

Current Status of Carbon Ion Radiotherapy
openaire  

Some of the next articles are maybe not open access.

Related searches:

Clinical Indications for Carbon Ion Radiotherapy

Clinical Oncology, 2018
Compared with photon and proton therapy, carbon ion radiotherapy (CIRT) offers potentially superior dose distributions, which may permit dose escalation with the potential for improved sparing of adjacent normal tissues. CIRT has increased biological effectiveness leading to increased tumour killing compared with other radiation modalities.
Mohamad, O., Yamada, S., Durante, M.
openaire   +3 more sources

Carbon Ion Radiotherapy for Unresectable Retroperitoneal Sarcomas

International Journal of Radiation Oncology*Biology*Physics, 2009
To evaluate the applicability of carbon ion radiotherapy (CIRT) for unresectable retroperitoneal sarcomas with regard to normal tissue morbidity and local tumor control.From May 1997 to February 2006, 24 patients (17 male and 7 female) with unresectable retroperitoneal sarcoma received CIRT. Age ranged from 16 to 77 years (median, 48.6 years).
Itsuko, Serizawa, Kenji, Kagei, Tadashi, Kamada, Reiko, Imai, Shinji, Sugahara, Tohru, Okada, Hiroshi, Tsuji, Hisao, Ito, Hirohiko, Tsujii   +8 more
openaire   +2 more sources

Carbon ion radiotherapy of skull base chondrosarcomas

International Journal of Radiation Oncology*Biology*Physics, 2007
To evaluate the effectiveness and toxicity of carbon ion radiotherapy in chondrosarcomas of the skull base.Between November 1998 and September 2005, 54 patients with low-grade and intermediate-grade chondrosarcomas of the skull base have been treated with carbon ion radiation therapy (RT) using the raster scan technique at the Gesellschaft für ...
Daniela, Schulz-Ertner, Anna, Nikoghosyan, Holger, Hof, Bernd, Didinger, Stephanie E, Combs, Oliver, Jäkel, Christian P, Karger, Lutz, Edler, Jürgen, Debus   +8 more
openaire   +2 more sources

Workflow of Carbon-Ion Radiotherapy

2013
The carbon-ion radiotherapy system consists of oncology information system (OIS), radiotherapy treatment planning system (RTPS), and beam delivery system (BDS), which is similar to the standard radiotherapy system. However, there are some differences, such as a big accelerator system, no gantry system (except HIT), and an efficient workflow system. The
Toshiyuki Shirai, Yuka Takei
openaire   +1 more source

Treatment Planning for Carbon Ion Radiotherapy

2001
One of the main objectives in radiotherapy is the conformai delivery of the prescribed dose to the target volume, whereas the surrounding healthy tissue and critical structures should be spared as much as possible. In comparison with conventional photon beams, therapeutic ion beams in general offer the advantage of a depth dose distribution with a ...
M. Krämer, O. Jäkel, T. Haberer, G. Kraft, D. Schardt, D. Scholz, U. Weber   +6 more
openaire   +1 more source

Carbon Ion Radiotherapy

Bengal Journal of Cancer, 2022
openaire   +1 more source